Direkt zum Inhalt
Merck
  • Preparation and in vitro evaluation of benzylsulfanyl benzoxazole derivatives as potential antituberculosis agents.

Preparation and in vitro evaluation of benzylsulfanyl benzoxazole derivatives as potential antituberculosis agents.

European journal of medicinal chemistry (2008-08-13)
Vera Klimesová, Jan Kocí, Karel Waisser, Jarmila Kaustová, Ute Möllmann
ZUSAMMENFASSUNG

A set of 2-benzylsulfanyl derivatives of benzoxazole was synthesized and evaluated for their in vitro antimycobacterial activity against Mycobacterium tuberculosis, non-tuberculous mycobacteria and multidrug-resistant M. tuberculosis. The activities were expressed as the minimum inhibitory concentration (MIC) in mmol/L. The substances showed similar activity against all tested strains. The lead compounds in the set, dinitro derivatives exhibited significant activity against both sensitive and resistant strains of M. tuberculosis and also against non-tuberculous mycobacteria. To facilitate drug design of benzoxazole as potential antituberculosis agent, we have explored the quantitative structure-activity relationship (QSAR). We demonstrated that lower lipophilicity has significant contribution to activity. Dinitrobenzylsulfanyl derivative of benzoxazole represents the promising small-molecule synthetic antimycobacterials.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Supelco
Isoniazid, analytical standard, ≥99% (TLC)
Sigma-Aldrich
2-Mercapto-benzoxazol, 95%